Literature DB >> 11854121

Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.

Giuseppina Basta1, Guido Lazzerini, Marika Massaro, Tommaso Simoncini, Piero Tanganelli, Caifeng Fu, Thomas Kislinger, David M Stern, Ann Marie Schmidt, Raffaele De Caterina.   

Abstract

BACKGROUND: The products of nonenzymatic glycation and oxidation of proteins, the advanced glycation end products (AGEs), form under diverse circumstances such as aging, diabetes, and kidney failure. Recent studies suggested that AGEs may form in inflamed foci, driven by oxidation or the myeloperoxidase pathway. A principal means by which AGEs alter cellular properties is through interaction with their signal-transduction receptor RAGE. We tested the hypothesis that interaction of AGEs with RAGE on endothelial cells enhances vascular activation. METHODS AND
RESULTS: AGEs, RAGE, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin are expressed in an overlapping manner in human inflamed rheumatoid synovia, especially within the endothelium. In primary cultures of human saphenous vein endothelial cells, engagement of RAGE by heterogeneous AGEs or Nepsilon(carboxymethyl)lysine-modified adducts enhanced levels of mRNA and antigen for vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin. AGEs increased adhesion of polymorphonuclear leukocytes to stimulated endothelial cells in a manner reduced on blockade of RAGE.
CONCLUSIONS: AGEs, through RAGE, may prime proinflammatory mechanisms in endothelial cells, thereby amplifying proinflammatory mechanisms in atherogenesis and chronic inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854121     DOI: 10.1161/hc0702.104183

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  144 in total

1.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

Authors:  Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 3.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

4.  Mechanical properties of normal and diseased cerebrovascular system.

Authors:  Ali P Ebrahimi
Journal:  J Vasc Interv Neurol       Date:  2009-04

5.  An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental glomerulosclerosis.

Authors:  Harin Rhee; Sang Heon Song; Ihm Soo Kwak; Il Young Kim; Eun Young Seong; Dong Won Lee; Soo Bong Lee
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

6.  The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.

Authors:  Su Jin Jeong; Beom Jin Lim; Sungha Park; Donghoon Choi; Hye Won Kim; Nam Su Ku; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

7.  The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.

Authors:  Yu-Pei Fan; Ching-Chih Hsia; Kuang-Wen Tseng; Chih-Kai Liao; Tz-Win Fu; Tsui-Ling Ko; Mei-Miao Chiu; Yang-Hsin Shih; Pei-Yu Huang; Yi-Chia Chiang; Chih-Ching Yang; Yu-Show Fu
Journal:  Stem Cells Transl Med       Date:  2015-12-30       Impact factor: 6.940

Review 8.  Advanced-glycation end products in insulin-resistant states.

Authors:  Georgia Soldatos; Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

9.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

10.  Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior.

Authors:  Brooke N Mason; Alina Starchenko; Rebecca M Williams; Lawrence J Bonassar; Cynthia A Reinhart-King
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.